MedTrace Logo

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy

NCT06121518 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2024-04-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy in Essential Hypertension Patients

Conditions

  • Essential Hypertension

Interventions

DRUG

D064 and D702, QD

Experimental Group Subjects assigned to this group are treated with D064, D702

DRUG

D064 and Placebo of D702, QD

Comparator Group Subjects assigned to this group are treated with D064, placebo of D702

DRUG

Placebo of D064 and D702, QD

Comparator Group Subjects assigned to this group are treated with D702, placebo of D064

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Jinho Shin, M.D, Ph.D · Hanyang University Seoul Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-31
Primary Completion
2024-03-22
Completion
2024-03-26

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121518 on ClinicalTrials.gov